Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 1105-1110

  Plump, Andrew S ^a   Masucci Magoulas, Lori ^b   Bruce, Can ^b   Bisgaier, Charles L ^c,d   Breslow, Jan L ^a   Tall, Alan R ^b,e  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c PFIZER INC   (United States)

^d Esperion Therapeutics Inc   (United States)

^e Division of Molecular Medicine ^*  (United States)

Author keywords

Atherogenesis; Fractional catabolic rate; HDL metabolism; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CATABOLISM; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0032917975     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.1105     Document Type: Article

References (46)

1. Tall AR. Plasma lipid transfer proteins. Annu Rev Biochem. 1995;64: 235-257.
2. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high density lipoprotein caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med. 1990;323:1234-1238.
3. Inazu A, Jiang X, Haraki T, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall AR. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 1994;94:1872-1882.
4. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature. 1989;342:448-451.
5. Zhong S, Sharp DS, Grove JS, Bruce C, Katsuhiko Y, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutations in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 1996;97:2917-2923.
6. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang X, Shelanski SA, Breslow JL, Tall AR. Reduced high density lipoprotein cholesterol in human choiesteryl ester transfer protein transgenic mice. J Biol Chem. 1991;266:10796-10801.
7. Marotti KR, Castle CK, Murray RW, Rehberg EF, Polites HG, Melchior GW. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism-insights from studies with transgenic mice. Arterioscler Thromb. 1992;12:736-744.
8. Melchior GW, Castle CK, Murray RW, Blake WL, Dinh DM, Marotti KR. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1994;269:8044-8051.
9. Francone OL, Rover L, Haghpassand M. Increased preβ-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res. 1996;37:1268-1277.
10. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ether transfer protein. Nature. 1993;364:73-75.
11. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL. Hypertriglyccridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. J Clin Invest. 1993;92:1143-1152.
12. Masucci-Magoulas L, Plump A, Jiang X, Walsh A, Breslow JL, Tall AR. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apoE and LDL receptor gene knock-out mice: a novel mechanism signals changes in plasma cholesterol levels. J Clin Invest. 1996;97:154-161.
13. Hayek T, Chajek-Shaul T, Walsh A, Agellon LB, Moulin P, Tall AR, Breslow JL. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of HDL cholesterol levels. J Clin Invest. 1992;90:505-510.
14. Plump AS, Scott CJ, Breslow J. Human apolipoprotein A-I gene expression raises HDL and suppresses atherosclerosis in the apo E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91:9607-9611.
15. Paszty C, Maeda N, Verstuyft J, Ruhin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1994;94:899-903.
16. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall AR. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice: dependence on natural flanking sequences. J Clin Invest. 1992;90:1290-1295.
17. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Ruhin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
18. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 1994;93:1885-1893.
19. Chajek-Shaul T, Hayek T, Walsh A, Breslow JL. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl ethers. Proc Natl Acad Sci U S A. 1991;88: 6731-6735.
20. 131I-labeled plasma proteins. Phys Med Biol. 1957;2:36-53.
21. Paigen B, Morrow A, Holmes PA, Mitchel D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987;68: 231-240.
22. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91:9607-9611.
23. Allain CC, Poon LS, Chan CSG, Fu PC, Richmond W. Enzymatic determination of total serum cholesterol. J Clin Invest. 1974;20:470-475.
24. Kieft KA, Bocan TMA, Krause BR. Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel-filtration chromatography. J Clin Invest. 1991;32:859-866.
25. Wolle S, Via DP, Chan L, Cornicelli JA, Bisgaier CL. Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia. J Clin Invest. 1995;96:260-272.
26. Whitlock ME, Swenson TL, Ramakrishnan R, Leonard MT, Marcel YL, Milne RW, Tall AR. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: effects on lipoprotein composition and HDL cholesteryl ester metabolism. J Clin Invest. 1989;84:129-137.
27. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest. 1996;96:2071-2074.
28. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
29. Navab M, Imes SS, Hama SY. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyle chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88: 2039-2046.
30. Khoo JC, Miller E, McLoughlin P, Steinberg D. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res. 1990;31:645-652.
31. Kunitake ST, Jarvis MR, Hamilton RL, Kane JP. Binding of transition metals by apolipoprotein A-I containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A. 1992; 89:6993-6997.
32. Mackness MI, Arrol S, Abott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Arteriosclerosis. 1993;104:129-135.
33. Shimada M, Ishibashi S, Inaba T, Yagyu H, Harada K, Osuga J, Ohashi K, Yazaki Y, Yamada N. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A. 1996;93:7242-7246.
34. Khoo JC, Pittman RC, Rubin EM. Selective uptake of HDL cholesteryl esters is active in transgenic mice expressing human apolipoprotein A-I. J Lipid Res. 1995;36:593-600.
35. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Gosselin ML, Dixon KL, Deeds JD, Acton SL, Tall AR, Huszar D. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1998;95:4619-4624.
36. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I, reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997;94: 12610-12615.
37. Li H, Reddick RL, Maeda N. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler Thromb. 1993;13:1814-1821.
38. Cohen RD, Castellani LW, Qiao J, Lenten BJV, Lusis AJ, Reue K. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apoliprotein A-IV. J Clin Invest. 1997;99:1906-1916.
39. Duverger N, Tremp G, Caillaud J, Emmanuel F, Castro G, Fruchart J, Steinmetz A, Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 1996;273:966-968.
40. Knecht TP, Pittman RC. A plasma membrane pool of cholesteryl esters that may mediate the selective uptake of cholesteryl esters from high-density lipoproteins. Biochim Biophy Acta. 1989;1002:365-375.
41. Masucci-Magoulas L, Goldberg IJ, Bisgaier CL, Serajuddin H, Francone OL, Breslow JL, Tall AR. A mouse model with features of familial combined hyperlipidemia. Science. 1997;275:391-394.
42. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda Takemura K, Hayashi K, Matsuzawa Y. Atherosclerotic disease in marked hyperalphalipoproteinemia: combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol. 1995;15:1849-1856.
43. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Kaoru K, Matsuzawa Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Arterioscler Thromb Vasc Biol. 1997;17:1053-1059.
44. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard J, Fruchart J, Ducimetiere P, Apfelbaum M, Cambien F. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96.1664-1671.
45. Moriyama Y, Okamura T, Inazu A, Doi M, Iso H, Mouri Y, Ishikawa Y, Suzuki H, Iida M, Koizumi J, Mabuchi H, Komachi Y. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med. 1998;27:659-667.
46. Sugano M, Makino N. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits. J Biol Chem. 1996;271:19080-19083.